Human CDON/CDO/CDON1 ORF/cDNA clone-Adenovirus particle (NM_001243597)

Cat. No.: vGMAP-SPh-220

Pre-made Human CDON/CDO/CDON1 Adenovirus for CDON overexpression in-vitro and in-vivo. The CDON adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified CDON-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.

At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.

Target products collection

Go to CDON/CDO products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name Adenovirus Grade Adenovirus quantity
vGMAP-SPh-220 Human CDON Adenovirus particle Research Grade-In vitro 1E+10PFU (1E+10pfu/ml×1ml)
5E+10PFU (1E+10pfu/ml×5ml)
1E+11PFU (1E+10pfu/ml×10ml)
Research Grade-In vivo 1E+11PFU (1E+11pfu/ml×1ml)
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMAP-SPh-220
Gene Name CDON
Accession Number NM_001243597
Gene ID 50937
Species Human
Product Type Adenovirus particle (overexpression)
Insert Length 3864 bp
Gene Alias CDO,CDON1,HPE11,ORCAM
Fluorescent Reporter EGFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter EF1
Resistance Amplicin
ORF Nucleotide Sequence ATGCATCCGGATCTTGGACCCTTATGTACACTGCTGTATGTTACTCTTACAATTCTGTGCTCTTCTGTGAGTTCAGACTTGGCACCTTATTTTACTTCTGAGCCGCTCTCTGCTGTCCAGAAACTTGGTGGACCTGTAGTACTGCATTGTTCTGCTCAACCTGTGACCACTCGTATCTCATGGCTGCATAACGGAAAAACATTGGATGGAAACCTGGAACATGTTAAGATTCATCAGGGGACTCTGACAATTCTTTCTCTCAACTCCTCTCTTTTGGGTTACTACCAGTGCCTTGCCAACAATAGCATCGGTGCCATTGTGAGTGGCCCTGCGACAGTATCTGTGGCAGTTCTTGGTGATTTTGGTTCATCCACAAAGCATGTTATTACAGCAGAAGAAAAAAGTGCTGGTTTCATTGGCTGCAGGGTACCGGAGAGTAACCCCAAAGCTGAGGTGCGCTATAAAATCCGGGGAAAATGGCTGGAACATTCCACAGAGAATTACTTAATCCTTCCATCAGGAAATCTTCAGATTTTGAATGTATCCTTAGAGGACAAGGGATCATACAAATGTGCAGCTTATAATCCTGTCACACATCAATTAAAAGTTGAACCTATTGGCCGAAAGCTCCTTGTGAGTCGTCCTTCTTCAGATGATGTTCACATTCTTCACCCCACCCATTCACAGGCATTAGCTGTTCTTTCTCGTAGCCCTGTAACCTTGGAGTGTGTGGTGAGTGGGGTCCCGGCTCCTCAAGTGTATTGGCTAAAGGACGGGCAGGACATTGCACCAGGAAGCAACTGGAGAAGGTTGTATTCTCATCTTGCCACTGATAGCGTTGACCCGGCGGACTCCGGAAACTATTCCTGCATGGCGGGAAACAAGTCTGGAGATGTAAAATATGTGACTTACATGGTTAATGTACTTGAACATGCTTCCATTTCTAAAGGACTACAGGATCAGATAGTGTCTCTGGGTGCCACAGTACACTTTACCTGCGACGTTCATGGGAACCCAGCCCCCAACTGTACCTGGTTTCACAATGCACAGCCTATTCATCCTTCTGCACGACATCTAACTGCAGGAAACGGACTGAAAATCAGTGGGGTTACTGTGGAAGATGTTGGGATGTATCAGTGTGTAGCAGATAATGGGATTGGATTTATGCACTCTACTGGAAGACTTGAAATTGAAAATGACGGTGGATTCAAGCCAGTTATAATTACGGCACCAGTAAGTGCAAAGGTTGCAGACGGAGACTTTGTTACTCTGTCCTGCAATGCCAGTGGGCTGCCGGTTCCGGTCATTCGTTGGTATGACAGCCATGGATTGATAACCAGCCATCCATCTCAAGTCCTGAGATCGAAATCCCGAAAATCACAGTTATCAAGACCTGAGGGCTTGAACCTGGAGCCTGTGTACTTCGTCCTGTCCCAAGCTGGTGCAAGCTCTCTCCATATTCAGGCTGTGACTCAGGAACATGCGGGGAAATACATCTGCGAAGCTGCAAATGAACATGGTACCACACAGGCAGAAGCATCTCTCATGGTTGTTCCTTTTGAAACAAATACAAAAGCAGAGACAGTCACACTTCCTGATGCTGCTCAGAATGATGACAGAAGTAAGAGAGATGGTTCAGAAACTGGGTTACTGAGCTCATTTCCGGTGAAGGTCCATCCCAGTGCAGTGGAATCAGCACCAGAGAAAAACGCCAGCGGCATCTCTGTTCCTGATGCCCCCATCATACTGAGCCCCCCACAGACCCACACACCAGACACGTACAACCTGGTGTGGAGGGCAGGCAAGGATGGTGGGCTGCCCATCAATGCTTACTTTGTGAAGTATCGAAAGCTGGATGATGGGGTTGGCATGCTGGGAAGCTGGCACACGGTTCGAGTCCCAGGAAGTGAAAATGAGCTCCATTTAGCTGAGCTGGAGCCATCTAGTCTTTATGAAGTCTTGATGGTAGCAAGAAGCGCAGCAGGTGAAGGCCAACCTGCCATGCTTACCTTCCGAACCAGCAAAGAAAAAACAGCGTCATCAAAAAACACCCAGGCATCCTCTCCACCCGTGGGCATCCCTAAGTATCCCGTTGTTTCAGAGGCTGCAAACAACAATTTTGGAGTGGTACTTACAGATTCCTCTAGGCACAGTGGAGTTCCAGAGGCACCAGATCGGCCTACCATCTCCACTGCATCAGAGACATCAGTCTATGTCACTTGGATTCCTCGGGCAAACGGGGGTTCTCCAATCACTGCCTTCAAAGTCGAATATAAACGGATGAGGACCAGCAATTGGCTGGTGGCAGCTGAAGACATCCCTCCTTCCAAACTTTCAGTGGAAGTTCGTAGTTTAGAACCAGGTTCAACATACAAATTTAGGGTCATTGCCATCAACCATTATGGTGAGAGTTTTCGGAGTTCAGCATCTCGTCCTTATCAAGTGGTTGGGTTCCCCAATCGCTTTTCCAGCCGTCCAATAACTGGACCTCACATTGCATACACAGAGGCTGTCAGCGATACTCAGATCATGCTAAAGTGGACGTACATTCCATCAAGTAACAATAACACTCCCATTCAAGGATTTTATATCTATTACCGACCAACAGATAGTGACAATGACAGTGATTACAAGAGGGATGTTGTAGAAGGTTCAAAGCAGTGGCACATGATTGGCCACCTGCAGCCAGAAACCTCCTATGACATTAAAATGCAATGCTTCAATGAAGGAGGAGAAAGTGAATTTAGCAATGTGATGATCTGCGAGACTAAAGTGAAACGTGTTCCTGGAGCTTCTGAATATCCTGTCAAAGACTTGAGTACCCCTCCAAATTCTTTGGGAAGTGGAGGAAATGTGGGGCCTGCAACCAGCCCTGCCAGAAGCAGTGACATGTTATATCTGATCGTTGGCTGTGTGCTGGGCGTCATGGTCCTCATTCTGATGGTTTTCATTGCAATGTGCCTGTGGAAGAATCGCCAGCAGAATACCATACAAAAATATGACCCACCAGGATATCTCTACCAAGGATCAGATATGAACGGGCAGATGGTGGACTACACCACTCTCTCAGGAGCAAGTCAGATAAATGGAAATGTTCACGGAGGCTTCCTAACCAATGGCGGTCTCAGCAGTGGCTATTCCCACCTTCACCATAAGGTCCCCAATGCAGTCAATGGAATTGTGAATGGGAGCCTAAATGGAGGGCTTTACTCCGGGCACAGCAACTCTCTAACCAGGACACACGTGGATTTTGAACATCCTCATCATCTAGTGAATGGTGGTGGAATGTACACGGCCGTGCCTCAGATTGACCCTCTGGAGTGTGTTAACTGCCGAAATTGTCGAAACAACAATAGGTGTTTCACCAAAACCAACAGCACTTTCAGCAGCAGCCCTCCTCCTGTGGTCCCTGTGGTAGCACCTTATCCTCAGGATGGTTTGGAAATGAAGCCCCTCAGTCACGTGAAGGTGCCTGTATGCCTGACTTCCGCAGTCCCTGATTGTGGCCAGTTGCCGGAGGAGAGCGTCAAGGACAATGTGGAACCAGTCCCTACTCAGCGTACCTGCTGTCAGGACATTGTAAATGACGTCAGCTCTGATGGCTCAGAAGATCCAGCAGAGTTCAGCAGAGGTCAGGAAGGCATGATCAACCTTAGGATTCCAGATCATCTTCAGTTAGCTAAGAGCTGTGTATGGGAAGGAGACAGCTGTGCCCATTCAGAAACAGAGATCAACATTGTAAGTTGGAATGCTCTTATTTTGCCACCTGTCCCCGAGGGCTGTGCTGAGAAGACAATGTGGTCTCCACCTGGCATTCCTTTAGACAGCCCGACAGAGGTCCTTCAGCAGCCCCGGGAAACCTGA
ORF Protein Sequence MHPDLGPLCTLLYVTLTILCSSVSSDLAPYFTSEPLSAVQKLGGPVVLHCSAQPVTTRISWLHNGKTLDGNLEHVKIHQGTLTILSLNSSLLGYYQCLANNSIGAIVSGPATVSVAVLGDFGSSTKHVITAEEKSAGFIGCRVPESNPKAEVRYKIRGKWLEHSTENYLILPSGNLQILNVSLEDKGSYKCAAYNPVTHQLKVEPIGRKLLVSRPSSDDVHILHPTHSQALAVLSRSPVTLECVVSGVPAPQVYWLKDGQDIAPGSNWRRLYSHLATDSVDPADSGNYSCMAGNKSGDVKYVTYMVNVLEHASISKGLQDQIVSLGATVHFTCDVHGNPAPNCTWFHNAQPIHPSARHLTAGNGLKISGVTVEDVGMYQCVADNGIGFMHSTGRLEIENDGGFKPVIITAPVSAKVADGDFVTLSCNASGLPVPVIRWYDSHGLITSHPSQVLRSKSRKSQLSRPEGLNLEPVYFVLSQAGASSLHIQAVTQEHAGKYICEAANEHGTTQAEASLMVVPFETNTKAETVTLPDAAQNDDRSKRDGSETGLLSSFPVKVHPSAVESAPEKNASGISVPDAPIILSPPQTHTPDTYNLVWRAGKDGGLPINAYFVKYRKLDDGVGMLGSWHTVRVPGSENELHLAELEPSSLYEVLMVARSAAGEGQPAMLTFRTSKEKTASSKNTQASSPPVGIPKYPVVSEAANNNFGVVLTDSSRHSGVPEAPDRPTISTASETSVYVTWIPRANGGSPITAFKVEYKRMRTSNWLVAAEDIPPSKLSVEVRSLEPGSTYKFRVIAINHYGESFRSSASRPYQVVGFPNRFSSRPITGPHIAYTEAVSDTQIMLKWTYIPSSNNNTPIQGFYIYYRPTDSDNDSDYKRDVVEGSKQWHMIGHLQPETSYDIKMQCFNEGGESEFSNVMICETKVKRVPGASEYPVKDLSTPPNSLGSGGNVGPATSPARSSDMLYLIVGCVLGVMVLILMVFIAMCLWKNRQQNTIQKYDPPGYLYQGSDMNGQMVDYTTLSGASQINGNVHGGFLTNGGLSSGYSHLHHKVPNAVNGIVNGSLNGGLYSGHSNSLTRTHVDFEHPHHLVNGGGMYTAVPQIDPLECVNCRNCRNNNRCFTKTNSTFSSSPPPVVPVVAPYPQDGLEMKPLSHVKVPVCLTSAVPDCGQLPEESVKDNVEPVPTQRTCCQDIVNDVSSDGSEDPAEFSRGQEGMINLRIPDHLQLAKSCVWEGDSCAHSETEINIVSWNALILPPVPEGCAEKTMWSPPGIPLDSPTEVLQQPRET

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-MP0245-Ab Anti-CDON/ CDO1/ HPE11 monoclonal antibody
    Target Antigen GM-Tg-g-MP0245-Ag CDON VLP (virus-like particle)
    ORF Viral Vector pGMLP-SPh-080 Human CDON Lentivirus plasmid
    ORF Viral Vector pGMAP-SPh-220 Human CDON Adenovirus plasmid
    ORF Viral Vector vGMLP-SPh-080 Human CDON Lentivirus particle
    ORF Viral Vector vGMAP-SPh-220 Human CDON Adenovirus particle


    Target information

    Target ID GM-MP0245
    Target Name CDON
    Gene Group Identifier
    （Target Gene ID in Homo species)         		50937
    Gene ID 100064474 (Equus caballus), 101087264 (Felis catus), 489296 (Canis lupus familiaris), 50937 (Homo sapiens)
    50938 (Rattus norvegicus), 536011 (Bos taurus), 57810 (Mus musculus), 714039 (Macaca mulatta)
    Gene Symbols & Synonyms CDON,Cdon,CDO,Ihog,CDON1,HPE11,ORCAM,Cdo,Cd0,Orcam
    Target Alternative Names CDON,Cell adhesion molecule-related/down-regulated by oncogenes,CDO,Ihog,CDON1,HPE11,ORCAM
    Uniprot Accession O35158,Q32MD9,Q4KMG0
    Additional SwissProt Accessions: Q4KMG0,O35158,Q32MD9
    Uniprot Entry Name
    Protein Sub-location Transmembrane Protein
    Category
    Disease
    Disease from KEGG
    Gene Ensembl ENSECAG00000017335, ENSCAFG00845009814, ENSG00000064309, ENSBTAG00000009315, ENSMUSG00000038119, ENSMMUG00000007628
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.